title: Pancreas after kidney transplantation: HLA mismatch does not preclude success.
authors.affiliation: Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.
authors.forename: G P
authors.initials: GP
authors.lastname: Basadonna
authors.forename: L A
authors.initials: LA
authors.lastname: Auersvald
authors.forename: S C
authors.initials: SC
authors.lastname: Oliveira
authors.forename: A L
authors.initials: AL
authors.lastname: Friedman
authors.forename: M I
authors.initials: MI
authors.lastname: Lorber
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use; D014019:Tissue Donors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D016559:Tacrolimus